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Abstract
Background: The ideal method to encourage uptake of clinical guidelines in hospitals is not
known. Several strategies have been suggested. This study evaluates the impact of academic
detailing and a computerised decision support system (CDSS) on clinicians' prescribing behaviour
for patients with community acquired pneumonia (CAP).
Methods: The management of all patients presenting to the emergency department over three
successive time periods was evaluated; the baseline, academic detailing and CDSS periods. The rate
of empiric antibiotic prescribing that was concordant with recommendations was studied over time
comparing pre and post periods and using an interrupted time series analysis.
Results: The odds ratio for concordant therapy in the academic detailing period, after adjustment
for age, illness severity and suspicion of aspiration, compared with the baseline period was OR =
2.79 [1.88, 4.14], p < 0.01, and for the computerised decision support period compared to the
academic detailing period was OR = 1.99 [1.07, 3.69], p = 0.02. During the first months of the
computerised decision support period an improvement in the appropriateness of antibiotic
prescribing was demonstrated, which was greater than that expected to have occurred with time
and academic detailing alone, based on predictions from a binary logistic model.
Conclusion: Deployment of a computerised decision support system was associated with an early
improvement in antibiotic prescribing practices which was greater than the changes seen with
academic detailing. The sustainability of this intervention requires further evaluation.
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Background
With the rapidly expanding body of medical knowledge,
clinicians need access to appropriate, relevant informa-
tion to guide their clinical decision making. For many
conditions, clinical experts have used available evidence
and experience to generate guidelines that endeavour to
assist clinicians, and improve patient outcomes. A major
problem, however, has been finding the best strategies to
implement these guidelines in a busy hospital environ-
ment. [1-3] Group lectures, one to one academic detail-
ing, laminated cards and advertising material such as
posters have all been tried with variable success. [4-7]
With the increasing role played by computers as a source
of information in the hospital setting, computerised deci-
sion support may provide a useful alternate strategy. [8-
11]
At the Royal Melbourne Hospital, a transferable web
based computerised decision support system was devel-
oped, with the capacity to present any guideline or algo-
rithm. [12] We chose in the first instance to deploy a
guideline for the management of patients with commu-
nity acquired pneumonia (CAP) as this is one of the most
common conditions presenting to hospital emergency
departments. International and national guidelines have
been produced to guide the management of CAP [13-15],
but uptake has been poor. [16]
The general aim of this study was to describe the impact
of different methods of guideline promotion on clinician
prescribing behaviour. More specifically, a comparison of
the impact of both academic detailing (AD) and a compu-
terised decision support system (CDSS) on the manage-
ment of patients with CAP in an emergency department
(ED) was examined. The outcomes of interest included
the prescription of antibiotics that were concordant with
guideline recommendations, the early identification of
the severely ill patients and adjustment of antibiotics to
meet recommendations for prescribing in the severely ill
group, and adjustment of antibiotics to accommodate
known patient allergies.
Methods
Design
A two stage pre and post intervention cohort study, and a
time series analysis
Setting
This study was performed at the Royal Melbourne Hospi-
tal, an urban adult tertiary teaching hospital with 350
beds including 14 intensive care unit (ICU) beds. The
emergency department assesses 50,000 patients per year,
leading to 16,000 admissions to hospital. This hospital
did not have an electronic medical record or a computer-
ised order entry system. Over 30 different doctors were
working in the ED at any point in time over the study peri-
ods, and the allocation of doctors to patients was not
structured. A computerised antibiotic approval system
restricting access to ceftriaxone was also in operation over
all three time periods of this study. Its implementation pre
dated the commencement of this study. It approved ceftri-
axone use for all patients with severe pneumonia, and its
content agreed with the CAP guideline content.
Participants
This study described the prescribing behaviour of doctors
(both senior and junior medical staff) managing patients
in the ED. Specifically, the study focused on antibiotic
prescribing for all patients who were initially diagnosed
with CAP by the treating clinician in the ED.
Intervention
The study extended over three distinct time periods. The
first, (or 'baseline') period was from April 2003–March
2004. The second (or 'academic detailing') period (AD)
was February 2005–October 2005 and the third (or 'com-
puterised decision support') period (CDSS) was from
April 2006–September 2006.
During the first ('baseline') time period, electronic and
paper copies of national antibiotic prescribing guidelines
were available to staff in the ED [13] but no particular
additional efforts were made to encourage uptake of the
guideline.
At the start of the second ('academic detailing') time
period, a program of academic detailing was initiated at
the hospital. This involved training two senior ED clini-
cians, a pharmacist and a nurse to provide academic
detailing to their colleagues. They spent one on one time
educating colleagues (doctors and pharmacists) about
antibiotic prescribing recommendations. These activities
were opportunistic and occurred during the usual rostered
hours. Interactions were not scheduled and no formal
documentation of AD encounters was made. Posters and
laminated cards with information about severity assess-
ments and appropriate antibiotic choices for patients with
CAP were distributed and actively promoted throughout
the ED during the academic detailing period. These per-
sonnel and advertising material remained available
throughout the following ('computerised decision sup-
port') time period, but were not specifically promoted.
At the commencement of the computerised decision sup-
port period, the guideline for the management of patients
with CAP was deployed on an existing decision support
tool. This tool is a web-based transferable system that was
designed at the hospital using a .NET framework and
implemented in January 2005.BMC Medical Informatics and Decision Making 2008, 8:35 http://www.biomedcentral.com/1472-6947/8/35
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The CAP algorithm used the Pneumonia Severity Index
(PSI) to guide site of management decisions (inpatient vs.
outpatient care) and the modified British Thoracic Society
severity score (CURB) to highlight patients with severe
pneumonia who were likely to need review by the inten-
sive care unit (ICU) staff. [17,18] The program was inte-
grated with hospital databases containing patient
demographics and pathology results to facilitate rapid cal-
culation of scores required for these prediction rules. Use
of these scores was not, however mandated. Users could
choose to skip the score to obtain antibiotic advice alone.
Antibiotic allergy reminders were included. If a user had
previously registered an allergy for a patient this was pre-
sented, otherwise a reminder was given to check with the
patient. Detailed information was included about unu-
sual pathogens to consider, the most appropriate choice
of empiric antibiotics, the duration of therapy, and the
timing of change from intravenous to oral antibiotic ther-
apy. Users had access to medical literature via the Internet,
along with local interpretation of this literature within the
CDSS. Users could browse the CDSS content without log-
ging a patient in, so it could be used as an educational tool
as well as providing patient specific advice. There was gen-
eral agreement between the empiric antibiotic recommen-
dations made in the national guideline, the AD directives
and the content of the CDSS.
The CDSS was available hospital wide and its use was
entirely voluntary. All hospital clinicians could access it
via a shortcut on the desktop of any hospital computer.
No specific incentives were provided to encourage its use.
It was not triggered by any other computer systems. It
resided alongside other electronic hospital guidelines. An
introductory demonstration was provided to the ED staff
and to all staff at a hospital grand round. Thereafter, infec-
tious diseases registrars or pharmacists provided demon-
strations informally.
Data collection
All patient presentations to the ED were available for
inclusion in the study. Patients were prospectively identi-
fied from a database in the ED where the treating doctor
already routinely recorded the patient's diagnosis. All
patients with a diagnosis of pneumonia, chest infection,
lower respiratory tract infection, pleuritic chest pain,
cough, shortness of breath, and/or aspiration were identi-
fied. Patients were included in the study if they had a new
respiratory symptom, a new chest x-ray infiltrate consist-
ent with pneumonia, and if the initial assessment made
by the treating doctor was that the patient had pneumo-
nia.
Exclusion criteria included: Age <18 years, immunocom-
promised patients (corticosteroids ≥ 15 mg prednisolone/
day for ≥ 2 weeks, HIV positive with CD4 <200 umol/L,
transplant recipients on immunosuppressive therapy),
suspected or known severe acute respiratory syndrome
(SARS), nosocomial pneumonia (discharged from hospi-
tal in the previous 2 weeks, after an admission longer than
48 hours), and/or known suppurative lung diseases such
as cystic fibrosis or bronchiectasis.
Data were prospectively collected from the medical his-
tory by a single trained research nurse, according to a set
of specified rules. A single clinician was assigned to make
judgements about any difficult issues, and a random sam-
ple of these cases was cross checked with a second infec-
tious diseases physician. This group comprised 5% of the
total patient cohort (40 patients). Specific clinical and
pathological and radiological data available within the
first 24 hours were sought to allow calculation of severity
scores. [17,18] Clinicians' comments about suspicion of
aspiration, and documentation of known antibiotic aller-
gies were recorded. The time to antibiotic therapy was cal-
culated using the time of presentation, documented
electronically by the ED triage nurse, and the time of anti-
biotic administration as documented on the medication
chart by the nurse in ED or on the ward.
Information regarding ongoing antibiotic use was col-
lected. Any antibiotics that were clearly being used to treat
a separate infection (as described in the patient's medical
record) were not included. Where the duration of treat-
ment after discharge was not recorded, it was assumed to
be 5 days. Antibiotic costs were calculated using pharmacy
purchasing data. No actual changes in the cost of drugs
commonly prescribed for pneumonia occurred over the
study period. The admission criteria for ICU were based
entirely upon the treating clinician's assessment in all
time periods. No protocols or guidelines were enforced.
Clinicians were not aware that the study was being con-
ducted. The researchers had no clinical role in the ED over
the study period. There were no major changes in the
number or composition of staff in the ED, or their respon-
sibilities over the study period. This study was approved
by the ethics committee of Melbourne Health. Individual
consent from the clinicians or the patients involved was
not required.
Outcome measures
The primary outcome assessed was the prescription of
empiric antibiotic therapy that adequately covered the
likely pathogens (both typical and atypical) and was con-
cordant with recommendations. This included the combi-
nation of a recommended beta lactam (amoxicillin,
ampicillin, benzylpenicillin, ceftriaxone, cefotaxime or
cefuroxime) plus either a macrolide (erythromycin, roxi-
thromycin, clarithromycin or azithromycin) or doxycy-
cline. The use of moxifloxacin alone was also classed as
appropriate. Patients who received additional antibioticsBMC Medical Informatics and Decision Making 2008, 8:35 http://www.biomedcentral.com/1472-6947/8/35
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were still classed as appropriate, so long as their antibiotic
regimen included the recommended drugs (reflecting that
the patients at least received appropriate cover). The pos-
sibility that antibiotics were required for other concordant
problems was appreciated, and without detailed clinical
information, it was not possible to determine if this addi-
tional antibiotic use was unnecessary.
A number of secondary outcomes were also examined. For
patients who required ICU intervention at any time dur-
ing their admission, the proportion that were admitted
directly from the ED to the ICU was evaluated as a marker
of early recognition of severe disease. Similarly, the pro-
portion of patients requiring ICU management at any
time during their admission who were initially prescribed
the recommended empiric broad spectrum antibiotics for
severe pneumonia in the ED was compared. Appropriate
therapy for this group was defined as ceftriaxone (or ben-
zylpenicillin plus gentamicin), in combination with
either intravenous azithromycin or erythromycin. The use
of moxifloxacin alone was also deemed appropriate.
The number of patients prescribed an antibiotic to which
they had a documented allergy was examined. The overall
pattern of antibiotics prescribed, and the average cost of
antibiotics per patient, were assessed in each time period.
Finally, the time between presentation to the ED and the
administration of antibiotics was recorded.
Statistical methods
Baseline characteristics of subjects were compared
between the three periods using a chi-squared test of
homogeneity for categorical variables and analysis of var-
iance for continuous variables. An a priori level of statisti-
cal significance of 0.05 was assumed.
The baseline period extended over one year to give an
indication of the baseline pattern of change in the rate of
concordant prescribing over time, in the absence of any
intervention. The academic detailing period included
enough patients to detect an improvement in mean con-
cordance from 65% to 75% (188 patients, power = 0.8
and p = 0.05). The computerised decision support period
included enough patients to detect an expected further
improvement in concordance from 75% to 85% (120
patients, power = 0.8, p = 0.05).
Multivariable logistic models were used to compare the
mean proportions of concordance across the three peri-
ods, while adjusting for disease severity, age, and sus-
pected aspiration. Secondary outcome measures were
assessed in the same way. Specifically, among the patients
who required ICU admission, the proportion directly
admitted from ED to the ICU, and the proportion admin-
istered appropriate broad-spectrum empiric antibiotic
therapy, were compared. This was specifically recorded as
a measure of the degree of recognition of markers of
severe illness, which were a key focus of the guideline con-
tent. The proportion of patients with a known antibiotic
allergy who received that antibiotic was also compared.
Time to antibiotic administration was recorded as a meas-
ure of whether the CDSS delayed decision making to any
extent.
A time series analysis was performed to evaluate changes
in concordance of prescribing over time, covering all three
time periods. The rate of concordant prescribing was
expected to improve over time. Change in concordance
over time was assessed with a binary logistic model, incor-
porating month of treatment as a continuous variable.
The 'expected' proportion of concordant treatment at any
given time then plausibly corresponds to a regression line
fitted through the data. We hypothesized that the rate of
concordant prescribing after the intervention (in the third
time period) would be greater than that expected given
the observed trend before the intervention (the first and
second time periods). Statistical analysis was performed
using Stata version 9.0. [19]
Results
The demographic details of the patients in each of the
three time periods are presented in Table 1. During the
computerised decision support period (CDSS), patients
were generally older than those in the other two time peri-
ods (a greater proportion were aged >85 years), and less
likely to have received antibiotic therapy prior to presen-
tation. The observed death rate during the CDSS period
appeared to be higher than for the other two periods, but
this was largely explained by differences in the proportion
of patients aged over 85 years, and differences in the
number of patients who died in the ED for whom sup-
portive therapy was not thought appropriate
Table 2 details the comparisons in prescribing behaviour
over the three time periods. The odds ratio for having
received the recommended empiric antibiotic therapy to
cover both typical and atypical pathogens ('concordant
therapy') in the ED for the academic detailing period com-
pared to the baseline period was 2.58 [1.78, 3.73], p <
0.01, and after adjustment for age, severity (PSI class) and
suspicion of aspiration, OR = 2.79 [1.88, 4.14], p < 0.01.
The odds ratio for concordant therapy in the computer-
ised decision support period compared to the academic
detailing period was 2.03 [1.13, 3.66], p = 0.01, and after
adjustment for age, severity and aspiration, OR = 1.99
[1.07, 3.69], p = 0.02. The estimated effect over time
within each cohort did not appear to be substantially
altered by the inclusion of these covariates.BMC Medical Informatics and Decision Making 2008, 8:35 http://www.biomedcentral.com/1472-6947/8/35
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The effect of change over time was observed in more
detail. Figure 1 illustrates the percentage of empiric antibi-
otic prescriptions that were concordant with recommen-
dations per month over the entire period. Prescribing
patterns improved slowly over time. One year after release
of the guideline, in the absence of any promotional
efforts, (that is, at the end of the baseline period), the con-
cordance rate was around 60%. The change in the propor-
tion of concordant prescribing between the last month of
the baseline period and the first month of the academic
detailing period was +10.8% over 12 months. The change
in the proportion of concordant prescribing between the
last month of the academic detailing period and the first
month of the computerised decision support period was
+21.5% over 5 months. At the end of the study period, the
rate of concordant prescribing was high. The first month
post the CDSS intervention had a very high concordance
rate (100%) and thereafter the rate remained around
90%, although the study was not long enough to demon-
strate whether this level was maintained beyond 6
months.
Further analysis was performed to compare the observed
results with that which would be expected based upon an
underlying trend in improvement over time [11]. The
observed behaviour in the preceding time periods (over 3
years) were used to predict the expected prescribing
behaviour in the latter 6 month period of the study. Figure
2 shows the three regression lines that best fit the observed
rate of concordance over the three separate time periods,
and the concordance predicted from a logistic regression
model based upon the first and second time periods
extrapolated forward through the third time period (the
'expected' concordance). While it is important to note that
Table 1: Patient characteristics
Variable Baseline Academic detailing Computerised decision support Pvalue#
N = 392 N = 215 N = 133
Age: median (range) 74 (18–96) 73 (18–98) 79 (18–98) 0.05
Sex Female: n (%) 158 40.0% 100 46.0% 60 45.1% 0.29
Nursing home residents: n (%) 55 14.0% 31 14.0% 18 13.5% 0.97
Suspected aspiration: n (%) 39 9.9% 20 9.3% 7 5.3% 0.25
Antibiotics prior to ED: n (%) 100 25.5% 54 25.1% 18 13.5% 0.01
Known beta lactam allergy n (%) 42 10.7% 23 10.6% 21 15.8% 0.25
Non-immediate 13 6 15
Uncertain 21 17 2
Immediate 8 0 4
PSI class (%)
I 11.9% 13.4% 12.8%
II 14.5% 17.2% 14.3%
III 17.3% 14.8% 11.3%
IV 33.4% }56.1% 28.8% }54.4% 31.5% }61.6% 0.39
V 22.7% 25.6% 30.1%
CURB severe n (%) 182 46.4% 96 44.6% 55 41.3% 0.65
ICU admission any time n (%) 26 6.6% 12 5.6% 10 7.5% 0.76
Length of stay – days, median (range) 4 (1–76) 4 (1–51) 4 (1–41) 0.93
Death: Total n (%) 37 9.4% 14 6.5% 21 15.7% 0.15*
Death: (excl. died in ED) n (%) 35/390 8.9% 12/213 6.5% 16/128 7.8% 0.23*
Comorbidities: (%)
CCF 20.4 15.3 18.0 0.30
COAD 23.4 15.3 26.3 0.02
Neoplasia 13.7 14.4 16.5 0.73
CRF 11.9 13.0 12.7 0.92
Dementia 13.2 14.4 21.0 0.09
Alcohol 9.6 7.9 5.2 0.27
CVA 18.8 17.6 12.8 0.27
Diabetes 22.2 22.7 19.5 0.76
Age >85 19.6 12.5 27.0 <0.01
* Adjusted for age, # p values calculated using chi squared test for categorical variables and analysis of variance for continuous variables
ED: Emergency department, ICU: Intensive care unit, PSI: Pneumonia Severity Index, CURB: modified British Thoracic Society Severity score, CCF: 
Congestive cardiac failure, COAD: Chronic obstructive airways disease, CRF: Chronic renal failure, CVA: Cerebrovascular diseaseBMC Medical Informatics and Decision Making 2008, 8:35 http://www.biomedcentral.com/1472-6947/8/35
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such a regression line may be sensitive to outliers, there
were in fact few actual outliers in these actual data and the
likelihood of effect would be low.
During the first six months of the CDSS period, the pro-
portion of patients who were prescribed concordant ther-
apy was greater than would be expected based on the
observed trend. A confidence interval around the trend
line was determined, and this described the likelihood of
the observed results in the first month of the CDSS period
as having a p value of 0.06 based on the existing trend
alone.
Secondary outcomes were analysed as a measure of the
impact of the changes in prescribing on key areas of inter-
est. Regarding those patients who required ICU support,
the likelihood that recommended broad spectrum
empiric antibiotics were received in the ED increased over
time. The odds ratio for the academic detailing period
compared to the baseline period was 1.48 [0.35,6.25], p =
0.59, and the odds ratio for the CDSS period compared to
the AD period was 10.80 [0.99, 116.99], p = 0.051.
Improved early recognition of patients with severe illness
was suggested, with a greater proportion of patients
requiring ICU care going directly to ICU from the ED over
time (65% in baseline, 75% in the academic detailing
period and 80% in the period of computerised decision
support). The number of patients was too small to com-
ment upon whether this change was statistically signifi-
cant.
There appeared to be a lower likelihood of inappropri-
ately prescribing an antibiotic to a patient who had a doc-
umented allergy to that drug during the computerised
decision support period. Specifically, comparing the AD
period with the baseline, the odds of an allergy prescrib-
ing error were 0.99 [0.31, 3.16], p = 0.99; whereas when
the comparing the CDSS with the AD period, the odds
ratio for such a prescribing error was 0.47 [0.10, 2.19], p
= 0.33.
Table 3 describes the most frequent antibiotic combina-
tions prescribed to patients in each of the three time peri-
ods. The percentage of patients empirically prescribed a
cephalosporin was 38.2% for the baseline period, 38.1%
for the academic detailing period, and 42.8% for the com-
puterised decision support period. The average cost of
antibiotic therapy per patient was calculated for the three
patient groups. This calculation was adjusted for changes
in pricing over time, though in fact, very little change
occurred in the price of the antibiotics most frequently
prescribed for CAP during the study. While the average
cost per patient increased between the first and second
time periods, it fell in the third time period. Finally, the
time between a patient being admitted to the emergency
department, and an antibiotic being first administered to
Table 2: Outcomes
Outcome Baseline group Academic detailing group Computerised decision support 
group
P value#
N = 392 N = 215 N = 133
Patients receiving recommended antibiotic 
cover for typical and atypical pathogens*
211/341
61.9%
143/208
68.7%
113/126
89.7%
<0.01
Patients requiring ICU who went direct 
from ED
17/26
65.0%
9/12
75.0%
8/10
80%
0.68
Patients requiring ICU who received 
appropriate empiric broad spectrum 
antibiotics#
12/25
48.0%
5/11
45.0%
9/10
90%
<0.01
PSI class V patients who received 
appropriate empiric broad spectrum 
antibiotics#
9/70
12.8%
4/43
9.3%
10/38
26.3%
<0.01
PSI class IV&V patients who received 
appropriate empiric broad spectrum 
antibiotics #
30/341
8.6%
9/208
4.3%
5/39
12.8%
<0.01
CURB 'severe' patients who received 
appropriate empiric broad spectrum 
antibiotics#
14/155
9.0%
7/80
8.7%
20/49
40.8%
<0.01
Patients who received an antibiotic to which 
they had a known allergy
11/42
26.2%
6/23
26.1%
3/21
14.3%
0.50
Time from ED presentation to 
administration of antibiotic: median (range)
171 minutes
(15–1969)
158 minutes
(15–1154)
142 minutes
(10–1190)
<0.01
Average cost of antibiotics for pneumonia 
per patient
$72.07 $94.47 $84.04 NA
* = excluding patients suspected of having aspirated and patients who received no antibiotic treatment at all
# p values calculated using chi squared test for categorical variables and analysis of variance for continuous variables
ED: Emergency department, ICU: Intensive care unit, PSI: Pneumonia Severity Index, CURB: modified British Thoracic Society Severity scoreBMC Medical Informatics and Decision Making 2008, 8:35 http://www.biomedcentral.com/1472-6947/8/35
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the patient did not increase, and was actually found to
progressively fall over the three time periods, from 171 to
158 and then 142 minutes, p < 0.01.
Discussion
This study demonstrates the pattern of behavioural
change in emergency department clinicians over three and
a half years, and describes the changes surrounding differ-
ent interventions to promote a particular prescribing strat-
egy. In particular, it demonstrates that the
implementation of a computerised decision support sys-
tem was associated with greater improvement in prescrib-
ing practices than would have been expected based upon
the predictions made from actual prescribing observed
over the preceding 3 years.
The baseline period provides an example of the rate of
change of prescribing behaviour with passive, informal
means of information transfer. It shows that change is
slow, and that the rate of change falls with time. This is
consistent with the suggestion that while some clinicians
respond to recommendations early, others may be more
difficult to access, or more resistant to change, and change
may be harder to achieve in the later time periods.
The improvement in concordance of prescribing was not
dramatic with academic detailing, but appeared to be
greatest immediately after the CDSS was deployed. It is
likely that the interest generated by a novel system, and
the attention it received during early education sessions
contributed to the high initial concordance. Junior staff in
this ED rotated on average every three months, which
means that the impact of AD may not be sustained as new
staff enter the unit. It is important to note that 100% con-
cordance should not be expected in this context. The CAP
guideline represents a basic recommendation, and indi-
vidual patients vary from the average. In the case of CAP,
experienced clinicians would be expected to vary from the
guidelines for valid clinical reasons. It is impossible to
separate the effect of the computerised decision support
system itself, from the effect of the education sessions,
which would have increased awareness of the CAP guide-
line and its recommendations. A longer duration of fol-
low up after deployment of the CDSS would be required
to comment upon the sustainability of any change.
The CDSS was associated with changes in many of the sec-
ondary outcomes of interest that were not demonstrated
with academic detailing. In particular, better recognition
of patients with severe pneumonia, suggested by increased
use of recommended broad-spectrum empiric antibiotics
in those requiring ICU care was noted. This change
occurred without a major increase in the overall rate of
cephalosporin use or the average antibiotic costs per
patient. This may be because the content of the decision
support system highlighted this perceived problem, and
Percentage of empiric antibiotics prescribed that were concordant with recommendations per month Figure 1
Percentage of empiric antibiotics prescribed that were concordant with recommendations per month.
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the advice was consistent for all users. In contrast, with
passive transfer and academic detailing advice might be
less consistent.
One of the strengths of this paper is that our statistical
analysis has taken in to account the expectation that pre-
scribing practices would improve over time, in the
absence of intervention. [11] This improvement is pre-
sumably due to a 'learning effect' as information is dis-
seminated. It demonstrates that trends in prescribing
practices were already present before any specific interven-
tion and these should be acknowledged.
This is one of the first papers to compare the impact of a
CDSS with academic detailing alone in the same clinical
setting. To date, academic detailing has been one of the
more common strategies used to promote guidelines, but
it can be a labour intensive exercise. The staff members
who provided academic detailing attended a two-day
training session, and thereafter dedicated a portion of
their clinical time to training purposes. The information
provided to different staff members may have varied due
to time constraints or the interest of the trainer, and par-
ticular areas may not have been discussed. The CDSS, in
contrast, provided consistent advice, and could be
accessed whenever required by the clinicians. It required
an initial investment of clinician's time to develop and
test the algorithm, but thereafter did not consume any
additional staff resources.
To date, most evaluations of CDSS in hospitals have
described large purpose built systems, often in academic
centres in the USA with a specific interest in computerisa-
tion. [8,20] This paper, in contrast, describes a transfera-
ble web based computerised decision support system
which can be integrated with many existing clinical data-
bases in other hospitals. This study describes a clinical set-
ting that would be familiar to most tertiary Australian
hospitals. Previous reviewers have noted the lack of
reports of systems outside of the USA, and this paper
therefore provides an important contribution. [21]
The major limitation of this study is that the changes were
not compared with a separate control group. This study
used the same group of clinicians at different time points
as controls. In order to do this, the effect of time needed
to be taken into account. The predictions of prescribing
patterns that we have described are extrapolations beyond
the actual data, and make assumptions about patterns of
practice remaining similar over time. In this hospital, it
would not have been practical to separate control and
intervention groups without cross contamination. In
addition, such a study might increase clinician awareness
Table 3: The most frequent initial antibiotic combinations 
prescribed (described as percentage of patients)
Initial antibiotic combination Percentage of patients
Baseline period
Penicillin IV + roxithromycin 20.6%
Ceftriaxone 10.2%
Ceftriaxone + roxithromycin 9.2%
Penicillin IV 5.8%
Penicillin IV + doxycycline 5.3%
Ceftriaxone + erythromycin IV 4.3%
Academic detailing period
Penicillin IV + roxithromycin 27.4%
Ceftriaxone + roxithromycin 16.7%
Amoxycillin (oral)+ roxithromycin 8.3%
Ceftriaxone 6.9%
Roxithromycin 5.1%
Penicillin IV + doxycycline 4.2%
Computerised decision support period
Penicillin IV + roxithromycin 28.6%
Ceftriaxone + roxithromycin 17.3%
Ceftriaxone + azithromycin 12.8%
Ceftriaxone 6.7%
Penicillin IV + doxycycline 6.0%
Proportion of concordant therapy prescribed over time Figure 2
Proportion of concordant therapy prescribed over 
time. The solid lines indicate regression lines that best fit the 
observed data in each of the three time periods, demonstrat-
ing the percentage of empiric antibiotic therapy that was con-
cordant with recommendations per month over time. The 
broken line is a regression line that best fits the observed 
data in just the first and second time periods. This line is pro-
jected forward over the third time period to demonstrate 
the 'predicted' concordance if the underlying trend from the 
first two time periods was to continue. The horizontal 
arrows demonstrate the timing of the two interventions. The 
vertical arrow represents the difference between the 'pre-
dicted' concordance and the observed concordance after the 
computerised decision support system (CDSS) intervention.
Academic detailing 
CDSSBMC Medical Informatics and Decision Making 2008, 8:35 http://www.biomedcentral.com/1472-6947/8/35
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and introduce bias affecting prescribing practices.
Although multiple testing issues are a concern where sev-
eral hypothesis tests are performed, in this study the find-
ings comparing time periods were relatively consistent
across different variables and the statistical significance of
the effect was generally better than the 0.05 level.
It is also important to recognize that the successful imple-
mentation of CDSS depends heavily on the personnel and
the setting, hence separate hospitals or wards do not nec-
essarily provide accurate control groups for comparison.
The 'culture' within an institution has important effects
on guideline implementation strategies. Exploration of
the effect of a computerised decision support system on
the prescribing practices in other institutions would,
therefore, be of interest.
Conclusion
This study has demonstrated improved antibiotic pre-
scribing practices in a hospital setting associated with two
different strategies for implementation of guidelines. The
improvement in prescribing practices was initially more
significant with computerised decision support system
than with academic detailing alone, although this may
represent the effect of increased attention being given to a
novel system. Further exploration of the role of computer-
ised decision support system in hospitals is warranted to
particularly to assess the sustainability of the effect on cli-
nician decision-making at the point of care.
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